
Advanced TeleSensors is a medical device company that offers a touchless heart monitoring solution called Cardi/o®, utilizing advanced radar technology and proprietary machine learning algorithms originally developed at NASA’s JPL. This innovative product allows for real-time monitoring of heart rate, breath rate, and motion without the need for wearables, making it ideal for elderly care and individuals with health concerns. The company emphasizes comfort, privacy, and individual empowerment, aiming to provide peace of mind to families by alerting them to any abnormal health events. Founded in 2009 and headquartered in Austin, Texas, Advanced TeleSensors is positioned to capitalize on the growing demand for non-intrusive health monitoring solutions in various markets, including home health and wellness.

Advanced TeleSensors is a medical device company that offers a touchless heart monitoring solution called Cardi/o®, utilizing advanced radar technology and proprietary machine learning algorithms originally developed at NASA’s JPL. This innovative product allows for real-time monitoring of heart rate, breath rate, and motion without the need for wearables, making it ideal for elderly care and individuals with health concerns. The company emphasizes comfort, privacy, and individual empowerment, aiming to provide peace of mind to families by alerting them to any abnormal health events. Founded in 2009 and headquartered in Austin, Texas, Advanced TeleSensors is positioned to capitalize on the growing demand for non-intrusive health monitoring solutions in various markets, including home health and wellness.
Product: Cardi/o — touchless radar-based vital-sign monitor (heart rate, respiratory rate, HRV, motion)
Founded: 2009
Headquarters: Austin, Texas
Total funding: USD 2,960,000
Notable partner: Infineon Technologies (partnership announced)
Non-contact vital-sign monitoring for consumer, clinical and industrial use (home health, elder care, baby monitoring, equine).
2009
Medical devices / Healthtech
2000000.00
Announced to accelerate development and market readiness of Cardi/o
2960000.00